Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA

Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02390635	PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia	recruiting	Phase 1	77	M.D. Anderson Cancer CenterOTHER	1	Apr 17, 2026	clinicaltrials
NCT01139970	Veliparib and Temozolomide in Treating Patients With Acute Leukemia	completed	Phase 1	66	National Cancer Institute (NCI)NIH	1	Nov 20, 2025	clinicaltrials